Group 1 - The core viewpoint of the news is that Maide Medical (688310) has released its performance forecast for 2025, indicating significant revenue growth and a return to profitability [1][3] Group 2 - On January 26, Maide Medical's stock closed at 16.26 yuan, down 1.57%, with a turnover rate of 1.94% and a trading volume of 32,300 shares, amounting to a transaction value of 52.25 million yuan [1] - The company expects a total operating revenue of approximately 447.50 million yuan for the year 2025, representing a year-on-year increase of 62.81% [1][3] - The forecasted net profit attributable to the parent company is around 66.52 million yuan, indicating a turnaround from previous losses [1][3] - The net profit after deducting non-recurring gains and losses is estimated to be approximately 54.64 million yuan, also reflecting a return to profitability [1][3] - The growth in performance is primarily attributed to a significant increase in revenue from the combination of pharmaceutical and medical equipment intelligent devices [1]
股市必读:迈得医疗(688310)预计2025年全年营业收入4.47亿元